Search research articles
Contact Us
Filters
Showing results (731-740 of 1,216) with videos related to
Page
of 122
Sort By:
Biochemical Society Transactions
|
December 1, 1979
Incubation of 5-aminolaevulinate with erythrocyte haemolysates from normal and protein-deficient guinea pigs [proceedings]
S G Smith, M A El-Far, K R Rao, et al.
Journal of Medicinal Chemistry
|
August 1, 1989
5-HT1A-receptor antagonism: N-alkyl derivatives of (R)-(-)-8,11-dimethoxynoraporphine
J G Cannon, H Jackson, J P Long, et al.
European Journal of Clinical Pharmacology
|
January 1, 1994
The pharmacokinetics and pharmacodynamics of medifoxamine after oral administration in healthy elderly volunteers
N Gainsborough, M L Nelson, V Maskrey, et al.
British Journal of Haematology
|
August 22, 2003
Polymorphisms of interleukin-1alpha constitute independent risk factors for chronic graft-versus-host disease after allogeneic bone marrow transplantation
Hannah Cullup, Anne M Dickinson, James Cavet, et al.
The Prostate
|
March 11, 1998
Treatment of human prostate cancer cells with dolastatin 10, a peptide isolated from a marine shell-less mollusc
T Turner, W H Jackson, G R Pettit, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
May 24, 2011
A framework for addressing structural uncertainty in decision models
Christopher H Jackson, Laura Bojke, Simon G Thompson, et al.
Nature Immunology
|
July 20, 2004
T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation
Sharon H Jackson, Satish Devadas, Jaeyul Kwon, et al.
Transplantation
|
May 1, 2002
Risk factors for the development and progression of dyslipidemia after heart transplantation
Fatemeh Akhlaghi, Christopher H Jackson, Jayan Parameshwar, et al.
Eye (London, England)
|
January 1, 1994
Does topical flurbiprofen affect the pupillary response to acetylcholine?
H Jackson, C K Patel, M Westcott, et al.
British Journal of Clinical Pharmacology
|
February 1, 1995
The bioavailability and disposition of 1-(beta-D-arabinofuranosyl)-5-(1-propynyl)uracil (882C87), a potent, new anti-varicella zoster virus agent
R W Peck, R Wootton, D R Lee, et al.
Page
of 122
Search research articles
Search
Showing results (731-740 of 1,216) with videos related to
Sort By:
Page
of 122
Biochemical Society Transactions
|
December 1, 1979
Incubation of 5-aminolaevulinate with erythrocyte haemolysates from normal and protein-deficient guinea pigs [proceedings]
S G Smith, M A El-Far, K R Rao, et al.
Journal of Medicinal Chemistry
|
August 1, 1989
5-HT1A-receptor antagonism: N-alkyl derivatives of (R)-(-)-8,11-dimethoxynoraporphine
J G Cannon, H Jackson, J P Long, et al.
European Journal of Clinical Pharmacology
|
January 1, 1994
The pharmacokinetics and pharmacodynamics of medifoxamine after oral administration in healthy elderly volunteers
N Gainsborough, M L Nelson, V Maskrey, et al.
British Journal of Haematology
|
August 22, 2003
Polymorphisms of interleukin-1alpha constitute independent risk factors for chronic graft-versus-host disease after allogeneic bone marrow transplantation
Hannah Cullup, Anne M Dickinson, James Cavet, et al.
The Prostate
|
March 11, 1998
Treatment of human prostate cancer cells with dolastatin 10, a peptide isolated from a marine shell-less mollusc
T Turner, W H Jackson, G R Pettit, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
May 24, 2011
A framework for addressing structural uncertainty in decision models
Christopher H Jackson, Laura Bojke, Simon G Thompson, et al.
Nature Immunology
|
July 20, 2004
T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation
Sharon H Jackson, Satish Devadas, Jaeyul Kwon, et al.
Transplantation
|
May 1, 2002
Risk factors for the development and progression of dyslipidemia after heart transplantation
Fatemeh Akhlaghi, Christopher H Jackson, Jayan Parameshwar, et al.
Eye (London, England)
|
January 1, 1994
Does topical flurbiprofen affect the pupillary response to acetylcholine?
H Jackson, C K Patel, M Westcott, et al.
British Journal of Clinical Pharmacology
|
February 1, 1995
The bioavailability and disposition of 1-(beta-D-arabinofuranosyl)-5-(1-propynyl)uracil (882C87), a potent, new anti-varicella zoster virus agent
R W Peck, R Wootton, D R Lee, et al.
Page
of 122